Business At a crossroads, big pharma, including J&J and Merck, is gearing up to face substantial revenue losses from their blockbuster drugs. Let’s talk about the pharmaceutical scene, where companies like Merck are making notable progress after the expiration of Keytruda’s patent. According to Merck’s CEO,... Ashley RosaJanuary 28, 2024